Yu Hao Zhikai Lei Nanjing Shi Lingying Yu Weiqin Ji Xianfeng Zhang
10.3389/fendo.2021.743517
Front Endocrinol (Lausanne)
2022 Jan 14;12:743517.
calcium-sensing receptor hypocalciuric hypercalcemia inactivating mutation parathyroid gland radiofrequency ablation
CC BY
https://pubmed.ncbi.nlm.nih.gov/35095753/
Hypercalcemia / surgery Parathyroid Glands / surgery Radiofrequency Ablation / methods Receptors, Calcium-Sensing / genetics
Hypercalcemia / surgery Parathyroid Glands / surgery Radiofrequency Ablation / methods Receptors, Calcium-Sensing / genetics Case Reports Research Support, Non-U.S. Gov't Adult Calcium / metabolism Calcium-Regulating Hormones and Agents / therapeutic use Cinacalcet / therapeutic use HEK293 Cells Humans Hypercalcemia / blood Male Mutation Parathyroid Glands / metabolism Parathyroid Hormone / blood Phenethylamines / pharmacology Propylamines / pharmacology Receptors, Calcium-Sensing / metabolism Treatment Failure CASR protein, human Calcium-Regulating Hormones and Agents N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine Parathyroid Hormone Phenethylamines Propylamines Receptors, Calcium-Sensing Calcium Cinacalcet
PMC8795859
35095753
Radiofrequency Ablation of Parathyroid Glands to Treat a Patient With Hypercalcemia Caused by a Novel Inactivating Mutation in CaSR
2022